Combination therapy with an SGLT2 inhibitor and GLP-1 receptor agonist:
Study Finds Diabetes Complications and Mental Health Disorders Are a 2-Way Street
Diabetes Dialogue: Stelo OTC Availability and Omnipod 5 for Type 2 Diabetes
Dexcom Announces Availability, Pricing of Stelo—First OTC Glucose Sensor
Diabetes Dialogue: Sotagliflozin for T1D and Other ADCES 2024 Highlights
HbA1c Highly Predicts NAFLD Disease Severity
Real-World Analysis Finds Tirzepatide Offers Greater Benefit than GLP-1 RAs for Heart, Kidney in T2D